These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9617571)

  • 1. PGE2 inhibits IL-2 and IL-4-dependent proliferation of CTLL-2 and HT2 cells.
    Gurlo T; Huang WW; von Grafenstein H
    Cytokine; 1998 Apr; 10(4):265-74. PubMed ID: 9617571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.
    Makoul GT; Robinson DR; Bhalla AK; Glimcher LH
    J Immunol; 1985 Apr; 134(4):2645-50. PubMed ID: 2857750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP suppresses interleukin-5 synthesis by human helper T cells via the downregulation of the calcium mobilization pathway.
    Kaminuma O; Mori A; Ogawa K; Kikkawa H; Nakata A; Ikezawa K; Okudaira H
    Br J Pharmacol; 1999 May; 127(2):521-9. PubMed ID: 10385254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 selectively inhibits human CD4+ T cells secreting low amounts of both IL-2 and IL-4.
    He X; Stuart JM
    J Immunol; 1999 Dec; 163(11):6173-9. PubMed ID: 10570308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation by prostaglandin E2 of interleukin release by T lymphocytes in mucosa.
    Barrera S; Lai J; Fiocchi C; Roche JK
    J Cell Physiol; 1996 Jan; 166(1):130-7. PubMed ID: 8557762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent interleukin 2 (IL-2) inhibitory activity of human serum is due to rapid killing of IL-2-dependent mouse cells.
    Pruett SB; Lackey A
    Clin Exp Immunol; 1987 Sep; 69(3):624-31. PubMed ID: 3117461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gangliosides interact with interleukin-4 and inhibit interleukin-4-stimulated helper T-cell proliferation.
    Chu JW; Sharom FJ
    Immunology; 1995 Mar; 84(3):396-403. PubMed ID: 7751022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine acts as an endogenous modulator of IL-2-dependent proliferation of cytotoxic T lymphocytes.
    Antonysamy MA; Moticka EJ; Ramkumar V
    J Immunol; 1995 Sep; 155(6):2813-21. PubMed ID: 7673697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine deprivation of naive CD8+ T cells promotes minimal cell cycling but maximal cytokine synthesis and autonomous proliferation subsequently: a mechanism of self-regulation.
    Sad S; Krishnan L
    J Immunol; 1999 Sep; 163(5):2443-51. PubMed ID: 10452979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling.
    Conrad DM; Hanniman EA; Watson CL; Mader JS; Hoskin DW
    J Cell Biochem; 2004 May; 92(2):387-99. PubMed ID: 15108363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced IL-4-mediated D10.G4.1 proliferation with suboptimal concentrations of anti-IL-4 receptor monoclonal antibodies.
    Lindqvist C; Lundström H; Oker-Blom C; Akerman KE
    J Immunol; 1993 Jan; 150(2):394-8. PubMed ID: 8419473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 suppresses nuclear factor-kappaB mediated interleukin 15 production in rheumatoid synoviocytes.
    Min SY; Kim WU; Cho ML; Hwang SY; Park SH; Cho CS; Kim JM; Kim HY
    J Rheumatol; 2002 Jul; 29(7):1366-76. PubMed ID: 12136890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diacylglycerol kinase inhibition prevents IL-2-induced G1 to S transition through a phosphatidylinositol-3 kinase-independent mechanism.
    Flores I; Jones DR; Ciprés A; Díaz-Flores E; Sanjuan MA; Mérida I
    J Immunol; 1999 Jul; 163(2):708-14. PubMed ID: 10395661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13.
    Trudeau J; Hu H; Chibana K; Chu HW; Westcott JY; Wenzel SE
    J Allergy Clin Immunol; 2006 Jun; 117(6):1446-54. PubMed ID: 16751012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells.
    Zeng L; An S; Goetzl EJ
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1420-6. PubMed ID: 9732406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective expansion of genetically modified T cells using an antibody/interleukin-2 receptor chimera.
    Sogo T; Kawahara M; Tsumoto K; Kumagai I; Ueda H; Nagamune T
    J Immunol Methods; 2008 Aug; 337(1):16-23. PubMed ID: 18589435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid stereospecific stimulation of lymphocytic metabolism by interleukin 2.
    Maddock EO; Maddock SW; Kelley VE; Strom TB
    J Immunol; 1985 Dec; 135(6):4004-8. PubMed ID: 3934271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-cell leukemia virus type 2 Tax protein induces interleukin 2-independent growth in a T-cell line.
    Kondo R; Higuchi M; Takahashi M; Oie M; Tanaka Y; Gejyo F; Fujii M
    Retrovirology; 2006 Dec; 3():88. PubMed ID: 17140451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
    Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
    J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.